Barrett & Company’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Barrett & Company’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	74,335 +11,229	+18%	+$272K	0.5%	36
2026 Q1	$1.53M	Buy	63,106 +7,181	+13%	+$174K	0.53%	34
2025 Q4	$1.36M	Buy	55,925 +4,091	+8%	+$99.4K	0.45%	35
2025 Q3	$1.26M	Buy	51,834 +68	+0.1%	+$1.65K	0.43%	38
2025 Q2	$1.26M	Buy	51,766 +68	+0.1%	+$1.64K	0.47%	37
2025 Q1	$1.25M	Buy	51,698 +724	+1%	+$17.4K	0.54%	37
2024 Q4	$1.22M	Buy	50,974 +12,389	+32%	+$298K	0.52%	38
2024 Q3	$940K	Buy	38,585 +246	+0.6%	+$5.93K	0.41%	42
2024 Q2	$910K	Buy	38,339 +74	+0.2%	+$1.75K	0.41%	45
2024 Q1	$911K	Buy	38,265 +62	+0.2%	+$1.48K	0.43%	42
2023 Q4	$914K	Buy	38,203 +20,394	+115%	+$476K	0.5%	43
2023 Q3	$412K	Buy	17,809 +3,054	+21%	+$71.3K	0.24%	81
2023 Q2	$346K	Buy	14,755 +8,039	+120%	+$190K	0.2%	91
2023 Q1	$160K	Buy	6,716 +4,816	+253%	+$114K	0.1%	137
2022 Q4	$44.4K	Hold	1,900	–	–	0.03%	237
2022 Q3	$44.4K	Buy	+1,900	New	+$45.4K	0.03%	237

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Barrett & Company's IBDS Position: Q2 2026 in Review

Barrett & Company increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 18% in Q2 2026, buying an estimated $272K and bringing the position to 74,335 shares worth $1.8M. The position accounts for 0.5% of the portfolio, ranked #36.

Barrett & Company first reported a position in IBDS in Q3 2022 and has held it in 16 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

Barrett & Company held 74,335 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $1.8M as of Q2 2026.
Barrett & Company bought 11,229 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $272K.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.5% of Barrett & Company's portfolio in Q2 2026, its #36 holding.
Barrett & Company first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2022 and has held it in 16 quarters since.
416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.